T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$1.82B |
| 2 |
Sea Limited
SE
|
+$1.38B |
| 3 |
Cisco
CSCO
|
+$1.16B |
| 4 |
Netflix
NFLX
|
+$1.14B |
| 5 |
Ingersoll Rand
IR
|
+$1.03B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.54B |
| 2 |
Amazon
AMZN
|
+$1.75B |
| 3 |
Amphenol
APH
|
+$1.65B |
| 4 |
KLA
KLAC
|
+$1.5B |
| 5 |
Xcel Energy
XEL
|
+$1.38B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.6% |
| 2 | Financials | 11.17% |
| 3 | Healthcare | 11.1% |
| 4 | Communication Services | 10.25% |
| 5 | Consumer Discretionary | 10.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2751
Verastem
VSTM
$638M
| $249K | ﹤0.01% |
46,827
+19,591
| +72% | +$121K |
|
2752
Investar Holding Corp
ISTR
$417M
| $248K | ﹤0.01% |
+9,078
| New | +$254K |
|
2753
Lexeo Therapeutics
LXEO
$375M
| $248K | ﹤0.01% |
43,132
+9,260
| +27% | +$65.6K |
|
2754
Real Brokerage
REAX
$501M
| $247K | ﹤0.01% |
98,416
+26,873
| +38% | +$81.3K |
|
|
INGM
2755
Ingram Micro Holding
INGM
$6.37B
| $246K | ﹤0.01% |
10,542
+736
| +8% | +$16K |
|
|
TTAM
2756
Titan America SA
TTAM
$2.95B
| $246K | ﹤0.01% |
16,360
+1,627
| +11% | +$27.8K |
|
|
NPB
2757
Northpointe Bancshares
NPB
$591M
| $245K | ﹤0.01% |
14,169
+3,723
| +36% | +$65.5K |
|
2758
RxSight
RXST
$293M
| $242K | ﹤0.01% |
39,130
+7,374
| +23% | +$61.2K |
|
2759
Quanterix
QTRX
$124M
| $241K | ﹤0.01% |
68,372
+24,594
| +56% | +$144K |
|
2760
Ranger Energy Services
RNGR
$401M
| $241K | ﹤0.01% |
14,008
+2,923
| +26% | +$47.4K |
|
2761
W&T Offshore
WTI
$575M
| $240K | ﹤0.01% |
70,231
+17,498
| +33% | +$43.3K |
|
2762
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23.7B
| $240K | ﹤0.01% |
2,200
| – | – |
|
2763
Arhaus
ARHS
$1.39B
| $239K | ﹤0.01% |
35,240
+4,787
| +16% | +$43.5K |
|
|
UPB
2764
Upstream Bio Inc
UPB
$388M
| $238K | ﹤0.01% |
26,434
+6,798
| +35% | +$122K |
|
2765
Enanta Pharmaceuticals
ENTA
$393M
| $237K | ﹤0.01% |
18,704
+4,294
| +30% | +$57.6K |
|
2766
Donegal Group Class A
DGICA
$693M
| $236K | ﹤0.01% |
13,691
+3,547
| +35% | +$64.4K |
|
2767
Haverty Furniture Companies
HVT
$443M
| $236K | ﹤0.01% |
+11,123
| New | +$271K |
|
2768
Parke Bancorp
PKBK
$406M
| $236K | ﹤0.01% |
+8,282
| New | +$226K |
|
2769
Inseego
INSG
$84.9M
| $235K | ﹤0.01% |
21,099
+2,862
| +16% | +$32.2K |
|
2770
KB Financial Group
KB
$41.3B
| $235K | ﹤0.01% |
+2,350
| New | +$236K |
|
2771
Spire Global
SPIR
$574M
| $235K | ﹤0.01% |
18,647
+2,424
| +15% | +$25.9K |
|
2772
Portillo's
PTLO
$327M
| $234K | ﹤0.01% |
44,176
+9,411
| +27% | +$51.2K |
|
2773
FuelCell Energy
FCEL
$1.54B
| $233K | ﹤0.01% |
35,652
+8,400
| +31% | +$64.8K |
|
2774
Granite Ridge Resources
GRNT
$683M
| $233K | ﹤0.01% |
39,613
+10,676
| +37% | +$53.6K |
|
2775
Alight
ALIT
$364M
| $232K | ﹤0.01% |
19,876
+1,971
| +11% | +$47K |
|
Similar funds
T. Rowe Price Associates's Q1 2026 Portfolio in Review
As of Q1 2026, T. Rowe Price Associates held 3,202 positions worth $865B, down 6.7% from $927B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
T. Rowe Price Associates's Q1 2026 filing shows 115 new, 2,022 increased, 804 reduced and 71 closed positions. Its largest new stake was Cenovus Energy: 23,907,299 shares worth $634M. The largest sale was Microsoft, an estimated $3.54B.
By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.
- T. Rowe Price Associates's largest Q1 2026 buy was Cenovus Energy: 23,907,299 shares worth $634M.
- T. Rowe Price Associates added most to Advanced Micro Devices in Q1 2026, an estimated $1.82B increase.
- T. Rowe Price Associates's biggest Q1 2026 reduction was Microsoft, cutting an estimated $3.54B.
- T. Rowe Price Associates fully exited CyberArk in Q1 2026, selling an estimated $251M.
- T. Rowe Price Associates's ten largest holdings make up 34% of its $865B portfolio in Q1 2026.
- T. Rowe Price Associates opened 115 new positions and closed 71 in Q1 2026.
- T. Rowe Price Associates's portfolio value fell 6.7% quarter-over-quarter to $865B.
Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.